CAC acquisition drives Baldwin's 30% revenue jump in Q2

Baldwin reported Q2 2026 commissions and fees of $488.8 million, up 30% from $376.2 million a year earlier, driven largely by its January 2026 CAC Group acquisition. Organic revenue growth was 2% (vs 11% in Q2 2025). IAS organic growth was -2%, while UCTS grew 6% and MIS grew 4%. GAAP net loss was $56 million. Q3 revenue guidance is $485–$495 million with mid-single-digit organic growth.

Original reporting
Published Jul 31, 2026, 5:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 5:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CAC acquisition drives Baldwin's 30% revenue jump in Q2 — source image
Decision brief

The 30-second read

$BWINNeutralMed
01

Why it matters

Traders should focus on the tension between acquisition-driven headline growth and underlying segment health: IAS organic growth at -2% versus UCTS at +6% and MIS at +4% (with QBE commission resets and Medicare underperformance adjustments). The guidance for Q3 revenue ($485M to $495M) and mid-single-digit organic growth is the key forward anchor.

02

Market read

This is a company-specific earnings and guidance update with acquisition effects, segment organic growth divergence, and balance-sheet changes that can drive near-term repricing.

03

What to watch

Leverage rose (debt $2.15B plus $302M revolved draw) and goodwill jumped, which could constrain future buybacks and tuck-in M&A, affecting valuation even if operating momentum improves.

Relevance 8/10Novelty 7/10Timing: post-market earnings release, with Q3 revenue guidance for immediate positioning

Background

Baldwin’s Q2 results are presented alongside the January 2026 merger with CAC Group, with organic growth metrics adjusted for acquisition-related accounting/integration effects.

Company-level read

Ticker impact

$BWINNeutralMedium confidence
Context

Baldwin reported Q2 commissions up 30% to $488.8M, driven largely by its January CAC acquisition, while IAS organic growth fell to -2%.

Expected impact

Choppy-to-lower bias possible if investors focus on -2% IAS organic growth and GAAP net loss, despite higher adjusted EPS and raised Q3 revenue range.

Evidence & confidence

The article provides a full earnings-style datapack: Q2 revenue/earnings, segment organic growth splits, GAAP loss drivers, goodwill and leverage changes, and explicit Q3 revenue guidance ($485M to $495M) with mid-single-digit organic growth.

Market effects

Broker-distribution peers may face read-across on how acquisition-led growth can mask weaker legacy retention and accounting-driven headwinds.

No specific regional market shock described beyond US-focused brokerage segments.

Limited, as the disclosed drivers are company-specific brokerage and underwriting dynamics.

Counterpoint

Investors may underweight the -2% IAS organic growth because management frames it as largely lapped headwinds and expects IAS retention easing into back half 2026.

Key entities

  • Baldwin

    Reported Q2 2026 commissions and fees of $488.8M (+30% y/y), with segment organic growth weakness in IAS and guidance for Q3 revenue and organic growth.

  • CAC Group

    CAC was acquired in January 2026 for $1.026B upfront consideration; it contributed $94M revenue this quarter and added 130 private equity client accounts.

  • Trevor Baldwin

    CEO cited normalized organic growth of 8% and discussed property-market softness and sales velocity momentum.

  • Brad Hale

    CFO guided Q3 revenue to $485M to $495M and discussed leverage constraints on share repurchases.

Related articles

$BWINMedAI 8/10

Baldwin (BWIN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Executive Director of Investor Relations - Bonnie Bishop Chief Executive Officer - Trevor Lowry Baldwin Chief Financial Officer - Bradford Lenzie Hale TAKEAWAYS Revenue -- $493 million, representing 2% total organic revenue growth during the period. Adjusted EBITDA -- $117 million, compared to $86 million in the prior-year period.

$BWINMed

Baldwin Insurance Group, Inc. (BWIN): Results of Operations and Financial Condition

Baldwin Insurance Group, Inc. (BWIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1fy2026q2earningsrele.htm EX-99.1 Document Exhibit 99.1 THE BALDWIN GROUP ANNOUNCES SECOND QUARTER 2026 RESULTS — Second Quarter Total Revenue Growth of 30% to $492.9 Million — — Second Quarter Net Loss of $56.0 Million; Adjusted EBITDA (1) Growth of 37% to $116.7

$PLTRMed

Stocks Erase Early Gains as Alphabet and Software Companies Fall

US stocks gave back early gains as software and defense shares fell. Alphabet dropped over 6% after Google DeepMind VP Jumper said to be leaving for Anthropic. Defense names slid after Iran said it made “major progress” with the US on a peace deal. Rates: 10-year Treasury yield rose to 4.489% amid $211B in auctions. Semiconductors and AI stocks led gains; Palantir, Intuit, Oracle fell, while SOXX hit a record.

$AHCOHighAI 9/10

Why AdaptHealth Stock Plummeted This Week

AdaptHealth (NASDAQ: AHCO) shares fell about 47% this week after the company reported Q2 results below expectations and issued sharply lower guidance. Analysts expected EPS of $0.15; AdaptHealth posted a loss of $1.07 per share. Sales rose 12.7% to $740.3M but missed forecasts. Full-year sales guidance was cut to $2.85B-$2.89B and EBITDA and FCF ranges were reduced.